164 related articles for article (PubMed ID: 35090226)
1. [Clinical characteristics and prognosis of 83 children with newly treated hepatoblastoma].
Wei LL; Ran Y; Li B; Su SF; Wei HX; Mao ST; Liu YF
Zhonghua Er Ke Za Zhi; 2022 Feb; 60(2):108-113. PubMed ID: 35090226
[No Abstract] [Full Text] [Related]
2. [Clinical features and prognostic analysis of hepatoblastoma in children under six years old].
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1063-1068. PubMed ID: 34933424
[No Abstract] [Full Text] [Related]
3. Clinical characteristics and prognostic factors of hepatoblastoma in 316 children aged under 3 years - a 14-year retrospective single-center study.
Zhi T; Zhang WL; Zhang Y; Hu HM; Huang DS
BMC Pediatr; 2021 Apr; 21(1):170. PubMed ID: 33849474
[TBL] [Abstract][Full Text] [Related]
4. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China.
Wang TY; Han YL; Gao YJ; Xu M; Gu S; Yin MZ; Zhong YM; Hu WT; Pan C; Tang JY
Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):471-478. PubMed ID: 31000431
[TBL] [Abstract][Full Text] [Related]
7. A multicenter prospective study on the management of hepatoblastoma in children: a report from the Chinese Children's Cancer Group.
Tang MJ; Ma XL; He XL; Pan WH; Zhang XH; Jiang SY; Gao J; Li F; Yao W; Gu S; Zhang WL; Zhao Q; Huang SH; Fang YJ; Liu W; Niu HZ; Wang CM; Sun LR; Gao H; Dai YP; Huang SG; Zhong ZY; Wang XG; Li ZR; Yang LC; Wu YM; Wang HM; Sun X; Yuan XJ
World J Pediatr; 2023 Sep; ():. PubMed ID: 37770810
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
9. [Clinical manifestations of Langerhans cell histiocytosis with multisystem involvement in 53 children].
Tang JJ; Xu XJ; Wang YC; Bai ST; Wang L; Ni XL; Liu YF
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):37-41. PubMed ID: 33397002
[No Abstract] [Full Text] [Related]
10. Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience.
Qiao GL; Li L; Cheng W; Ge J; Zhang Z; Wei Y
Eur J Surg Oncol; 2014 Nov; 40(11):1533-9. PubMed ID: 25103357
[TBL] [Abstract][Full Text] [Related]
11. Analysis of factors related to recurrence of paediatric hepatoblastoma - a single Centre retrospective study.
Yang W; Chen Y; Huang Y; Wang H
BMC Pediatr; 2019 Dec; 19(1):485. PubMed ID: 31822277
[TBL] [Abstract][Full Text] [Related]
12. [A follow-up report of childhood hepatoblastoma from 74 cases in a single center].
Wang TY; Pan C; Tang JY; Ye QD; Zhou M; Gao YJ; Hu WT
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):364-368. PubMed ID: 28482388
[No Abstract] [Full Text] [Related]
13. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
[TBL] [Abstract][Full Text] [Related]
14. Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma.
Koh KN; Namgoong JM; Yoon HM; Cho YA; Choi SH; Shin J; Kang SH; Suh JK; Kim H; Oh SH; Kim KM; Kim DY; Im HJ
Cancer Med; 2021 May; 10(10):3261-3273. PubMed ID: 33939313
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
16. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
Van Tornout JM; Buckley JD; Quinn JJ; Feusner JH; Krailo MD; King DR; Hammond GD; Ortega JA
J Clin Oncol; 1997 Mar; 15(3):1190-7. PubMed ID: 9060563
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.
Brown J; Perilongo G; Shafford E; Keeling J; Pritchard J; Brock P; Dicks-Mireaux C; Phillips A; Vos A; Plaschkes J
Eur J Cancer; 2000 Jul; 36(11):1418-25. PubMed ID: 10899656
[TBL] [Abstract][Full Text] [Related]
18. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Koh KN; Park M; Kim BE; Bae KW; Kim KM; Im HJ; Seo JJ
Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
[TBL] [Abstract][Full Text] [Related]
20. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
